Literature DB >> 27015521

Complications and safety of vagus nerve stimulation: 25 years of experience at a single center.

David Révész1,2, Bertil Rydenhag1,2, Elinor Ben-Menachem1,3.   

Abstract

OBJECTIVE The goal of this paper was to investigate surgical and hardware complications in a longitudinal retrospective study. METHODS The authors of this registry study analyzed the surgical and hardware complications in 247 patients who underwent the implantation of a vagus nerve stimulation (VNS) device between 1990 and 2014. The mean follow-up time was 12 years. RESULTS In total, 497 procedures were performed for 247 primary VNS implantations. Complications related to surgery occurred in 8.6% of all implantation procedures that were performed. The respective rate for hardware complications was 3.7%. Surgical complications included postoperative hematoma in 1.9%, infection in 2.6%, vocal cord palsy in 1.4%, lower facial weakness in 0.2%, pain and sensory-related complications in 1.4%, aseptic reaction in 0.2%, cable discomfort in 0.2%, surgical cable break in 0.2%, oversized stimulator pocket in 0.2%, and battery displacement in 0.2% of patients. Hardware-related complications included lead fracture/malfunction in 3.0%, spontaneous VNS turn-on in 0.2%, and lead disconnection in 0.2% of patients. CONCLUSIONS VNS implantation is a relatively safe procedure, but it still involves certain risks. The most common complications are postoperative hematoma, infection, and vocal cord palsy. Although their occurrence rates are rather low at about 2%, these complications may cause major suffering and even be life threatening. To reduce complications, it is important to have a long-term perspective. The 25 years of follow-up of this study is of great strength considering that VNS can be a life-long treatment for many patients. Thus, it is important to include repeated surgeries such as battery and lead replacements, given that complications also may occur with these surgeries.

Entities:  

Keywords:  AAN = American Academy of Neurology; EEG = electroencephalography; IQR = interquartile range; SUDEP = sudden unexplained death in epilepsy; VNS; VNS = vagus nerve stimulation; complications; epilepsy; implants; neurosurgery; treatment; vagus nerve stimulation

Mesh:

Year:  2016        PMID: 27015521     DOI: 10.3171/2016.1.PEDS15534

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  26 in total

1.  From neuroimunomodulation to bioelectronic treatment of rheumatoid arthritis.

Authors:  Alexandre Kanashiro; Gabriel Shimizu Bassi; Fernando de Queiróz Cunha; Luis Ulloa
Journal:  Bioelectron Med (Lond)       Date:  2018-05

Review 2.  Neurophysiology and neural engineering: a review.

Authors:  Arthur Prochazka
Journal:  J Neurophysiol       Date:  2017-05-31       Impact factor: 2.714

Review 3.  Vagus Nerve Stimulation for the Treatment of Epilepsy.

Authors:  Hernán F J González; Aaron Yengo-Kahn; Dario J Englot
Journal:  Neurosurg Clin N Am       Date:  2019-04       Impact factor: 2.509

Review 4.  Recent advances in epilepsy.

Authors:  Mark Manford
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

5.  Vagus nerve stimulation for treatment of drug-resistant epilepsy: a systematic review and meta-analysis.

Authors:  Mervyn Jun Rui Lim; Khi Yung Fong; Yilong Zheng; Christopher Yuan Kit Chua; Samuel Miny; Jeremy Bingyuan Lin; Vincent Diong Weng Nga; Hian Tat Ong; Rahul Rathakrishnan; Tseng Tsai Yeo
Journal:  Neurosurg Rev       Date:  2022-02-26       Impact factor: 3.042

6.  Vagus Nerve Stimulation for Tumor-Related Epilepsy: Does It Make Sense?

Authors:  Keng Lam; Jane Y Hwang
Journal:  Perm J       Date:  2021-06-09

7.  Transcutaneous Auricular Vagus Nerve Stimulation Differently Modifies Functional Brain Networks of Subjects With Different Epilepsy Types.

Authors:  Randi von Wrede; Thorsten Rings; Timo Bröhl; Jan Pukropski; Sophia Schach; Christoph Helmstaedter; Klaus Lehnertz
Journal:  Front Hum Neurosci       Date:  2022-06-23       Impact factor: 3.473

8.  Intra-operative monitoring as an adjuvant to standard vagus nerve stimulation implantation.

Authors:  Jason Labuschagne; Denis Mutyaba; Jacques Nel; Claudia Casieri
Journal:  Childs Nerv Syst       Date:  2021-07-23       Impact factor: 1.475

Review 9.  New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease.

Authors:  Feng Zhang; Ru-Jia Zhong; Cheng Cheng; Song Li; Wei-Dong Le
Journal:  Acta Pharmacol Sin       Date:  2020-12-02       Impact factor: 7.169

Review 10.  Drug-Resistant Epilepsy and Surgery.

Authors:  Jiyao Sheng; Shui Liu; Hanjiao Qin; Bingjin Li; Xuewen Zhang
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.